食品伙伴網(wǎng)訊   據(jù)美國聯(lián)邦公報消息，12月22日美國FDA發(fā)布條例，修訂獸藥條例，批準(zhǔn)亞甲基水楊酸桿菌肽（bacitracin methylene disalicylate）作為獸藥成分用于飼料。

    本次修訂申請由Pharmgate LLC公司提出。新條例批準(zhǔn)含亞甲基水楊酸桿菌肽的A類藥物性物品用于生產(chǎn)雞、火雞、野雞、鵪鶉、肉牛B類與C類藥物飼料。

    部分原文報道如下：

    The Food and Drug Administration （FDA） is amending the animal drug regulations to reflect approval of a supplemental new animal drug application （NADA） filed by Pharmgate LLC for the use of a Type A medicated article containing bacitracin methylenedisalicylate to manufacture Type B and Type C medicated feeds for chickens, turkeys, pheasants, quail, and feedlot cattle. This supplemental approval reflects FDA's effectiveness conclusions that relied on the National Academy of Sciences/National Research Council Drug Efficacy Study Group's evaluation of the effectiveness of this drug as well indications for use not subject to this review.

    原文鏈接：https://www.federalregister.gov/articles/2015/12/22/2015-32000/new-animal-drugs-for-use-in-animal-feeds-bacitracin-methylenedisalicylate